Hamilton Thorne Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Kate Torchilin
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | less than a year |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 1.5yrs |
Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb
Jul 29These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well
Aug 15At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?
May 25Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?
Mar 30These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely
Oct 05Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?
Jun 10Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around
May 15Is Hamilton Thorne (CVE:HTL) A Risky Investment?
Apr 12Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Mar 15When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?
Mar 01Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?
Feb 01Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years
Jan 19Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?
Jan 06What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?
Dec 24We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt
Dec 12Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?
Nov 30A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Nov 17CEO
Kate Torchilin
less than a year
Tenure
Dr. Ekaterina Torchilin PhD, MBA, also known as Kate, is President, Chief Executive Officer and Director of Hamilton Thorne Ltd. from January 15, 2024. She serves as Chief Executive Officer of Biocell Cent...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.3m | |
Chief Financial Officer | 2.2yrs | US$476.26k | 0.025% CA$ 84.3k | |
Vice President of Corporate Development | no data | US$395.95k | 0.021% CA$ 71.1k | |
Senior VP & GM of HT Inc. | 3.5yrs | US$391.30k | geen gegevens | |
Managing Director of Gynemed | no data | US$247.11k | geen gegevens | |
President | less than a year | geen gegevens | geen gegevens | |
Senior Vice President Global Operations & Sustaining Engineering and Management Rep | no data | US$165.49k | geen gegevens | |
Director of HR | no data | geen gegevens | geen gegevens | |
President of Embryotech Laboratories Inc | no data | geen gegevens | geen gegevens | |
Chief Executive Officer of Gynemed | no data | US$282.51k | geen gegevens | |
Finance Controller | no data | geen gegevens | geen gegevens |
1.5yrs
Gemiddelde duur
Ervaren management: Het managementteam van HTL wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.3m | |
President | less than a year | geen gegevens | geen gegevens | |
Lead Independent Director | 15.1yrs | US$113.50k | 0.32% CA$ 1.1m | |
Independent Director | 15.1yrs | US$66.00k | 13.15% CA$ 45.1m | |
Independent Director | 17.7yrs | US$103.50k | 0.17% CA$ 577.9k | |
Independent Director | 2.8yrs | US$113.50k | 0.060% CA$ 205.8k | |
Independent Director | 7.8yrs | US$66.00k | 0.095% CA$ 326.2k | |
Independent Director | 3.8yrs | US$66.00k | 0.062% CA$ 211.6k | |
Chairman Emeritus | 2.3yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens | |
Independent Director | 3.8yrs | US$113.50k | 0.064% CA$ 218.0k | |
Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
71yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van HTL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).